Determinants of COVID-19 disease severity in patients with underlying rheumatic disease

Background Over the month of April, Spain has become the European country with more confirmed cases of COVID-19 infection, after surpassing Italy on April 2nd. The community of Castile and León in Spain is one of the most affected by COVID-19 infection and the province of León has a total of 3711 ca...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical rheumatology 2020-09, Vol.39 (9), p.2789-2796
Hauptverfasser:	Santos, C. Sieiro, Morales, C. Moriano, Álvarez, E. Díez, Castro, C. Álvarez, Robles, A. López, Sandoval, T. Perez
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Age Factors Aged Aged, 80 and over Antibodies, Monoclonal, Humanized - therapeutic use Antirheumatic Agents - therapeutic use Antiviral Agents - therapeutic use Betacoronavirus C-reactive protein C-Reactive Protein - metabolism Cardiovascular disease Cardiovascular diseases Cardiovascular Diseases - epidemiology Comorbidity Coronavirus Infections - blood Coronavirus Infections - epidemiology Coronavirus Infections - mortality Coronavirus Infections - therapy Coronaviruses Corticosteroids COVID-19 Dehydrogenases Diabetes Diabetes mellitus Diabetes Mellitus - epidemiology Drug Combinations Dyslipidemia Dyslipidemias - epidemiology Epidemiology Female Ferritin Ferritins - blood Fever Fibrin Fibrinogen Degradation Products - metabolism Hospitalization Humans Hydroxychloroquine - therapeutic use Hypertension Hypertension - epidemiology Immunomodulation Impact and specific considerations of COVID-19 for clinical rheumatologists Infections Interleukin 1 Receptor Antagonist Protein - therapeutic use L-Lactate dehydrogenase L-Lactate Dehydrogenase - blood Lactic acid Length of Stay Lopinavir - therapeutic use Lung diseases Lung Diseases, Interstitial - epidemiology Male Medicine Medicine & Public Health Mortality Multivariate analysis Musculoskeletal diseases Odds Ratio Original Original Article Pandemics Patients Pneumonia, Viral - blood Pneumonia, Viral - epidemiology Pneumonia, Viral - mortality Pneumonia, Viral - therapy Prospective Studies Rheumatic diseases Rheumatic Diseases - epidemiology Rheumatic Diseases - physiopathology Rheumatology Risk Factors Ritonavir - therapeutic use SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Severity of Illness Index Spain - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!